Quick Answer
Innate Pharma SA reported Net Income of -$58.10 million for fiscal year 2022.
Innate Pharma SA Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2022 | -$58.10M | -10.0% |
| 2021 | -$52.81M | +17.5% |
| 2020 | -$63.98M | -208.2% |
| 2019 | -$20.76M | -780.8% |
| 2018 | $3.05M | — |
- Innate Pharma SA showed a decrease of -10.0% in Net Income compared to the prior fiscal year.
- Over the 2018–2022 period, Innate Pharma SA’s net income has declined by 2005.6% (from $3.05 million to -$58.10 million).
- The most recent figure is from Innate Pharma SA’s fiscal year 2022 report (Form 20-F), filed with the SEC on April 6, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: